|
Suppliers for CAS
218600-44-3
|
Properties | | CAS |
218600-44-3 | | Formula |
C31H41NO4 |
|
|
6 Registered suppliers
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C31H41NO4
Molecular Weight: 491.66154
Molecular Formula: C9H11ClN2O
Molecular Weight: 198.65
HS Code: 29242990
Molecular Formula: C31H41NO4 Molecular Weight: 491.66
More details are to be found here
Aea.ltd
P.R.China
Molecular Formula: C31H41NO4 Molecular Weight: 491.66
More details are to be found here
Finetech Industry Limited
P.R.China
More details are to be found here
BOC Sciences
USA
Description : Bardoxolone is a synthetic oleanane triterpenoid that exerts multifunctional activities in the control of cellular growth and differentiation. Bardoxolone is capable of activating the transcription factor peroxisome proliferator activator receptor-γ (PPARγ), its apoptotic effects in malignant cells have been shown to occur independently of PPARγ. Bardoxolone was developed as an potential drug for the improvement of hyperglycemia, proteinuria, glomerulus structure, serum creatine, which may in turn be beneficial to treat diabetic kidney diseases, cancer and thromboembolic events. - Molecular Weight :491.66
- Purity :> 98%
Molecular Formula : C31H41NO4 Canonical SMILES : CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C
InChI :
InChI=1S/C31H41NO4/c1-26(2)10-12-31(25(35)36)13-11-30(7)23(19(31)16-26)20(33)14-22-28(5)15-18(17-32)24(34)27(3,4)21(28)8-9-29(22,30)6/h14-15,19,21,23H,8-13,16H2,1-7H3,(H,35,36)/t19-,21-,23-,28-,29+,30+,31-/m0/s1
InChIKey :
TXGZJQLMVSIZEI-UQMAOPSPSA-N
Synonyms :
CDDO; RTA 401; RTA401; RTA-401
More details are to be found here
AK Scientific, Inc.
USA
Description : Bardoxolone is a synthetic oleanane triterpenoid that exerts multifunctional activities in the control of cellular growth and differentiation. Bardoxolone is capable of activating the transcription factor peroxisome proliferator activator receptor-γ (PPARγ), its apoptotic effects in malignant cells have been shown to occur independently of PPARγ. Bardoxolone was developed as an potential drug for the improvement of hyperglycemia, proteinuria, glomerulus structure, serum creatine, which may in turn be beneficial to treat diabetic kidney diseases, cancer and thromboembolic events. - Molecular Weight :491.66
- Purity :> 98%
Molecular Formula : C31H41NO4 Canonical SMILES : CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C
InChI :
InChI=1S/C31H41NO4/c1-26(2)10-12-31(25(35)36)13-11-30(7)23(19(31)16-26)20(33)14-22-28(5)15-18(17-32)24(34)27(3,4)21(28)8-9-29(22,30)6/h14-15,19,21,23H,8-13,16H2,1-7H3,(H,35,36)/t19-,21-,23-,28-,29+,30+,31-/m0/s1
InChIKey :
TXGZJQLMVSIZEI-UQMAOPSPSA-N
Synonyms :
CDDO; RTA 401; RTA401; RTA-401
More details are to be found here
|
details
details